Revolutionizing Stroke Care and Research

If you or a loved one has a stroke, every minute counts. After a stroke, brain cells surrounding the blocked artery begin to die. Rapid evaluations are essential to providing the right treatment to maximize recovery.

UVA Stroke Center provides the highest level of care for stroke patients undergoing an acute stroke episode, as well as those who have recently suffered from a stroke and require follow-up treatment. But what happens if a patient lives in a rual area and faces long transport times?

UVA is pioneering several programs to improve outcomes. Nina J. Solenski, MD, director of the Stroke Telemedicine and Tele-education program (STAT), and the team of neurologists at UVA are improving stroke care using technology to offer all patients access to around-the-clock, on-call specialty care. Meanwhile Andy Southerland, MD, MSc, is developing a novel diagnositc program to provide stroke consultation to rescue squad personnel through iPads, helping diagnose patients before they reach the hospital.

At UVA, patients have access to an additional layer of care. UVA was instrumental in the development of a clot-busting drug known as tPA; it’s still the only FDAapproved drug therapy for acute ischemic stroke. We also offer patients access to
surgical interventions such embolectomy—an emergency procedure, not offered in all hospitals, where doctors remove dangerous clots in the brain.

But we must do more. Karen Johnston, MD, MSc, is leading a clinical trial to determine the best way to maximize recovery for diabetic patients having a stroke. Her findings will set the standard of care nationally. Kevin Lee, PhD, is developing
novel ways to deliver therapeutics straight to the brain. Brad Worrall, MD, MSc, is harnessing what we are learning from the Human Genome Project to design new drug compounds. His investigation into the mechanics of stroke may one day give healthcare providers the ability to intervene before a stroke even happens